Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance Efficacy and Improve Safety

SIMPLE SUMMARY: Multiple myeloma, a cancer of the bone marrow, is the commonest cancer of adults in the Western World. Therapies have advanced dramatically in recent years, equating to improved survival and quality of life for patients, but those with resistant disease still have less favourable out...

Descripción completa

Detalles Bibliográficos
Autores principales: Swan, Dawn, Murphy, Philip, Glavey, Siobhan, Quinn, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046900/
https://www.ncbi.nlm.nih.gov/pubmed/36980705
http://dx.doi.org/10.3390/cancers15061819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046900/
https://www.ncbi.nlm.nih.gov/pubmed/36980705
http://dx.doi.org/10.3390/cancers15061819

Ejemplares similares